Trial
NCT06467435
Evaluation of K9 in Subjects With Thyroid Eye Disease (TED)
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Peter Timoney
Collaborators
Inflammasome Therapeutics
Condition
Thyroid Eye Disease
Intervention
Kamuvudine-9
Why stopped
Low enrollment status
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-01